More than 500 veterinary students gathered with researchers and industry leaders at the 2026 Veterinary Scholars Symposium, where Boehringer Ingelheim recognized emerging scientists for research in equine pregnancy loss and the gut microbiome’s influence on development.
Boehringer Ingelheim is investing in a new AI center in London to speed up research in both human and animal health, with a focus on smarter, faster drug development.
Zomedica has partnered with Boehringer Ingelheim to expand point-of-care testing for equine PPID, aiming to accelerate diagnosis and drive adoption of its TRUFORMA platform.
The Boehringer Ingelheim Cares Foundation is investing more than $2.5 million over three years to address veterinary burnout, workforce shortages, and care deserts in underserved communities across the U.S.
Sign up for free to receive the latest veterinary news, product announcements, and industry developments.